RECENT NEWS

In vitro diagnostics firm bioMérieux has announced the launch of SPINCHIP, an innovative point-of-care platform, featuring its first test for the measurement of high-sensitivity cardiac troponin I from a single drop of blood.

Eppendorf has expanded its centrifuge portfolio with the launch of the new SpinPro 8 R, a refrigerated, floor-standing high-speed centrifuge designed for demanding high-volume workflows.

Leica Biosystems has added two Paige digital pathology AI-enabled products from Tempus to its growing Aperio AI Store - a unified, interoperable digital pathology platform that provides multiple AI-powered applications in a single interface.

Irish laboratory supplier Cruinn Diagnostics has announced the acquisition of Katalyst Diagnostics, a UK-based point-of-care diagnostics business serving NHS and clinical customers across mental health, oncology, paediatrics and other specialist care settings.

Nearly one in three patients found to have antibodies against the bacterium that causes Lyme disease also had antibodies against one or more additional tick-borne pathogens, according to a new US study.

Circular Genomics' blood-based circular RNA (circRNA) biomarker platform is to be combined with Altoida's AI-powered Digital NeuroMarker platform, in a new collaboration designed to advance an integrated biology-and-function approach to diagnosing and treating Alzheimer's disease.

People with cancer will benefit from stronger national leadership to improve diagnosis, treatment and care, thanks to a reformed National Cancer Board, which met for the first time very recently.

Researchers have developed a new method that uses real-world evidence from the NHS Man Van pilot – a community cancer testing service - to identify and specify the requirements needed for new diagnostic pathways to work safely and effectively in practice.

A new study has found that erythrocyte sedimentation rate (ESR) samples measured by photometric rheology on innovative new analysers remained accurate for up to 28 hours at room temperature and 48 hours refrigerated, seven times longer than the traditional Westergren method's four-hour room-temperature limit.

The Medicines and Healthcare products Regulatory Agency (MHRA) has reaffirmed its commitment to strengthening regulatory collaboration with Malaysia following high-level discussions in Kuala Lumpur.

Roche has hosted the grand opening of the Roche Genentech Innovation Center Boston, expanding Roche and Genentech’s US research presence in one of the world’s leading life sciences communities.

Fuse Diagnostics, a developer of next-generation molecular diagnostics for point-of-need testing, has announced it has raised £1 million to accelerate commercialisation of its proprietary Flip product platform and expand manufacturing capabilities at its headquarters in Cambridge, UK.

An international research project bringing engineering and critical care expertise together to deepen understanding of sepsis and explore new approaches to blood-based diagnostics is being extended, following a €300,000 funding award from the Ministry of Science and Health of Rhineland-Palatinate, Germany.

UpFront Diagnostics has announced CE mark approval for LVOne - the world's first rapid blood test to diagnose stroke, and the first device of its kind to achieve this certification.

Leica Biosystems has launched its new HistoCore LIGHTNING C Laser Cassette Printer, designed to help laboratories standardise critical histopathology workflows, improve traceability and move from sample to answer with greater speed and certainty.

A new approach combining information about proteins in the blood with genomic data could help diagnose some people with rare conditions who remained undiagnosed after genome sequencing, according to new research.

Two leading UK research institutes, The Rosalind Franklin Institute and Henry Royce Institute will share just over £160 million of public funding from the UK government through UK Research and Innovation (UKRI) for the next five years, to develop new health tech and deepen understanding of advanced materials.

Scientists from the University of Galway have uncovered a surprising link between commonly used anti-cancer drugs and antibiotics that could offer a potential new approach to tackling infections caused by antibiotic-resistant microorganisms.

Young adults, particularly university students, remain at increased risk from meningococcal meningitis and septicaemia, with new figures showing that meningitis B (MenB) was responsible for 97% of invasive meningococcal disease cases in 15 to 24-year-olds (93 of 96 cases) in England during 2025 to 2026.

Researchers have demonstrated that a streamlined genetic testing approach could identify more people with inherited breast cancer risk, while reducing the burden on NHS breast and genetic services.